PRVCF

PreveCeutical Medical Inc.

USD

Set alert

Price alert · PRVCF

All alert types
0.01 USD 0.00 -23.36%
As of Oct 29, 2026
0.0125 Day range 0.0145
0.0038 52-week range 0.035
YTD
-53.67%
1 year
-76.57%
Open
0.0125
Prev close
0.0107
Mkt cap
5.23M
Vol
73.56K
Avg vol
25.51K
EPS
0.00
P/E
0.00
More statistics
Low
0.0125
High
0.0145

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for PRVCF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-39.45 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 4
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -9.0×
FY 2016: -0.4×FY 2017: -4.3×FY 2018: -1.2×FY 2019: -1.4×FY 2020: -3.6×FY 2021: -5.9×FY 2022: -8.7×FY 2023: -10.0×FY 2024: -12.0×FY 2025: -9.0×
FY 2016 5y median -9.0× FY 2025
P/S 0.0×
FY 2016: 39.1×FY 2017: 1393×FY 2018: 952×FY 2019: 1694×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -2.2×
FY 2016: -4.1×FY 2017: -90.0×FY 2018: -6.4×FY 2019: -1.1×FY 2020: -3.8×FY 2021: -2.5×FY 2022: -2.7×FY 2023: -2.2×FY 2024: -2.1×FY 2025: -2.2×
FY 2016 5y median -2.2× FY 2025
P/FCF -8.0×
FY 2016: -0.7×FY 2017: -6.9×FY 2018: -1.9×FY 2019: -5.2×FY 2020: 221×FY 2021: -21.1×FY 2022: -56.8×FY 2023: -43.2×FY 2024: -33.1×FY 2025: -8.0×
FY 2016 5y median -33.1× FY 2025
EV/EBITDA -5.5×
FY 2016: -0.4×FY 2017: -4.8×FY 2018: -1.6×FY 2019: -3.5×FY 2020: -8.2×FY 2021: -15.7×FY 2022: -15.5×FY 2023: -18.5×FY 2024: -25.0×FY 2025: -5.5×
FY 2016 5y median -15.7× FY 2025
EV/Sales 0.0×
FY 2016: 44.9×FY 2017: 1511×FY 2018: 1184×FY 2019: 3252×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -12.5%
FY 2016: -141.4%FY 2017: -14.5%FY 2018: -51.6%FY 2019: -19.4%FY 2020: 0.5%FY 2021: -4.7%FY 2022: -1.8%FY 2023: -2.3%FY 2024: -3.0%FY 2025: -12.5%
FY 2016 5y median -3.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: -6.7%FY 2017: 64.3%FY 2018: 69.4%FY 2019: 74.3%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -8709.6%FY 2017: -20207.8%FY 2018: -45172.1%FY 2019: -115704.4%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -10070.3%FY 2017: -32526.8%FY 2018: -76909.1%FY 2019: -118079.8%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 25.4%
FY 2016: 1056.3%FY 2017: 2100.2%FY 2018: 520.0%FY 2019: 79.8%FY 2020: 105.5%FY 2021: 42.1%FY 2022: 32.0%FY 2023: 22.0%FY 2024: 17.7%FY 2025: 25.4%
FY 2016 5y median 25.4% FY 2025
ROIC 339.0%
FY 2016: 1644.1%FY 2017: -186.0%FY 2018: -509.0%FY 2019: -1332.8%FY 2020: 361.3%FY 2021: 75.5%FY 2022: 78.8%FY 2023: 51.1%FY 2024: 37.3%FY 2025: 339.0%
FY 2016 5y median 75.5% FY 2025
ROA -109.4%
FY 2016: -1509.4%FY 2017: -278.2%FY 2018: -624.8%FY 2019: -417.3%FY 2020: -1256.7%FY 2021: -1071.3%FY 2022: -783.0%FY 2023: -701.9%FY 2024: -520.5%FY 2025: -109.4%
FY 2016 5y median -701.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: -28.4%FY 2018: -30.5%FY 2019: -80.4%FY 2020: -100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -314.1%
FY 2016: -4230.9%FY 2017: -66.1%FY 2018: -55.4%FY 2019: 49.8%FY 2020: 39.0%FY 2021: 58.0%FY 2022: -17.9%FY 2023: 9.0%FY 2024: 15.6%FY 2025: -314.1%
FY 2016 FY 2025
EPS (diluted) -22.7%
FY 2016: -281.4%FY 2017: -97.0%FY 2018: -15.5%FY 2019: 75.9%FY 2020: 7.8%FY 2021: 59.0%FY 2022: 17.6%FY 2023: 14.3%FY 2024: 8.3%FY 2025: -22.7%
FY 2016 FY 2025
Free Cash Flow -301.7%
FY 2016: -2595.2%FY 2017: -161.4%FY 2018: -68.8%FY 2019: 86.9%FY 2020: 106.2%FY 2021: -877.5%FY 2022: 53.8%FY 2023: -33.4%FY 2024: -44.3%FY 2025: -301.7%
FY 2016 FY 2025

Financial Health

Current Ratio 0.2×
FY 2016: 0.4×FY 2017: 4.5×FY 2018: 1.2×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.2×
FY 2016 5y median 0.0× FY 2025
Quick Ratio 0.2×
FY 2016: 0.3×FY 2017: 4.3×FY 2018: 1.2×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.2×
FY 2016 5y median 0.0× FY 2025
Debt / Equity -0.7×
FY 2016: -0.4×FY 2017: -7.9×FY 2018: -1.6×FY 2019: -1.1×FY 2020: -0.8×FY 2021: -0.7×FY 2022: -0.7×FY 2023: -0.7×FY 2024: -0.7×FY 2025: -0.7×
FY 2016 5y median -0.7× FY 2025
Net Debt / EBITDA -1.4×
FY 2016: -0.1×FY 2017: -0.4×FY 2018: -0.3×FY 2019: -1.7×FY 2020: -1.4×FY 2021: -3.5×FY 2022: -3.2×FY 2023: -4.3×FY 2024: -5.9×FY 2025: -1.4×
FY 2016 5y median -3.5× FY 2025
Interest Coverage -10.4×
FY 2016: -133×FY 2017: -17.6×FY 2018: -12.7×FY 2019: -6.1×FY 2020: -3.3×FY 2021: -1.9×FY 2022: -4.5×FY 2023: -3.1×FY 2024: -2485×FY 2025: -10.4×
FY 2016 5y median -4.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31